Method for treating infectious diseases with isothiocyanate functional compounds
Michael E. Silver, Lake City, MI (US)
Assigned to The William Yarbrough Foundation, Peoria, IL (US)
Filed by THE WILLIAM M YARBROUGH FOUNDATION, Peoria, IL (US)
Filed on Apr. 25, 2023, as Appl. No. 18/139,012.
Application 18/139,012 is a continuation of application No. 17/120,219, filed on Dec. 13, 2020, granted, now 11,633,375.
Application 17/120,219 is a continuation of application No. 16/453,972, filed on Jun. 26, 2019, granted, now 10,864,187, issued on Dec. 15, 2020.
Application 16/453,972 is a continuation of application No. 16/025,640, filed on Jul. 2, 2018, granted, now 10,335,387, issued on Jul. 2, 2019.
Application 16/025,640 is a continuation in part of application No. 15/838,444, filed on Dec. 12, 2017, granted, now 10,111,852, issued on Oct. 30, 2018.
Application 15/838,444 is a continuation of application No. 15/423,869, filed on Feb. 3, 2017, granted, now 9,839,621, issued on Dec. 12, 2017.
Application 15/423,869 is a continuation in part of application No. 14/867,626, filed on Sep. 28, 2015, granted, now 9,642,827, issued on May 9, 2017.
Application 14/867,626 is a continuation of application No. 14/867,585, filed on Sep. 28, 2015, granted, now 9,636,320, issued on May 2, 2017.
Application 14/867,585 is a continuation of application No. 14/519,510, filed on Oct. 21, 2014, granted, now 9,504,667, issued on Nov. 29, 2016.
Application 14/519,510 is a continuation of application No. 13/952,236, filed on Jul. 26, 2013, granted, now 8,865,772, issued on Oct. 21, 2014.
Claims priority of provisional application 61/676,093, filed on Jul. 26, 2012.
Prior Publication US 2023/0263763 A1, Aug. 24, 2023
1. A method of treating an infectious disease comprising the step of:
administering a product that is a leave-on product or a leave-in product to a patient having an infectious disease wherein the product comprises an isothiocyanate functional surfactant and an additional surfactant, wherein the additional surfactant is chosen from the group consisting of a non-ionic surfactant, an anionic surfactant, a cationic surfactant, a zwitterionic surfactant, and combinations thereof; and
wherein the additional surfactant consists a non-ionic surfactant and the non-ionic surfactant is chosen from a group comprising alcohols, alkanolamides, amine oxides, esters, ethers, silicone copolyols, cetearyl alcohol, ceteareth-20, nonoxynol-9, C12-15 pareth-9, POE (4) lauryl ether, cocamide DEA, glycol distearate, glyceryl stearate, PEG-100 stearate, sorbitan stearate, PEG-8 laurate, polyglyceryl-10 trilaurate, lauryl glucoside, octylphenoxy-polyethoxyethanol, PEG-4 laurate, polyglyceryl diisostearate, polysorbate-60, PEG-200 isostearyl palmitate, sorbitan monooleate, polysorbate-80 and wherein the isothiocyanate functional surfactant is in a protonated form and wherein the protonated form of the isothiocyanate functional surfactant is represented by the following chemical structure:
